The osteolytic response of macrophages to challenge with particles of Simplex P, Endurance, Palacos R, and Vertebroplastic bone cement particles in vitro

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 75, Issue 1, 2005, Pages 210-220

  Ingram, Joanne H ^a   Kowalski, Rick ^b   Fisher, John ^a   Ingham, Eileen ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Johnson Johnson Company   (United Kingdom)

Author keywords

Cytokines; IL 1 ; IL 6; Macrophages; Osteolysis; PMMA; TNF ; Wear particles

Indexed keywords

BIOMEDICAL ENGINEERING; CELL CULTURE; DURABILITY; POLYMETHYL METHACRYLATES; PROTEINS;

CYTOKINES; IL-1Β; IL-6; MACROPHAGES; OSTEOLYSIS; TNF-Α; WEAR PARTICLES;

BONE CEMENT;

BONE CEMENT; CALCIUM 45; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PALACOS; POLY(METHYL METHACRYLATE); TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CALVARIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGENERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOLYSIS; PARTICLE SIZE; PARTICULATE MATTER; PERITONEUM MACROPHAGE; VOLUMETRY; WEAR PARTICLE;

ANIMALS; BONE CEMENTS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; ENDOTOXINS; MACROPHAGES; MATERIALS TESTING; METHYLMETHACRYLATE; METHYLMETHACRYLATES; MICE; MICE, INBRED C3H; OSTEOLYSIS; POLYMETHYL METHACRYLATE;

EID: 25844439312     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30308     Document Type: Article

References (40)

1. Ingham E, Fisher J. Biological reactions to wear debris. Proc IMechE J Eng Med 2000;214H:21-37.
2. Matthews JB, Stone MH, Wroblewski BM, Fisher J, Ingham E. Evaluation of the response of primary human peripheral blood mononuclear phagocytes challenged with in vitro generated clinically relevant UHMWPE particles of known size and dose. J Biomed Mater Res B Appl Biomater 2000;44:296-307.
3. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. Comparison of the response of primary human peripheral blood mononuclear phagocytes from different donors to challenge with polyethylene particles of known size and dose. Biomaterials 2000;21:2033-2044.
4. Green TR, Fisher J, Matthews JB, Stone MH, Ingham E. Effect of size and dose on bone resorption activity of macrophages in vitro by clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res B Appl Biomater 2000;53: 490-497.
5. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005;26:1271-1286.
6. Green TR, Fisher J, Stone MH, Wroblewski,BM, Ingham E. Polyethylene particles of a critical size are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998;19:2297-2302.
7. McGrath LR, Shardlow DL, Ingham E, Andrews M, Ivory J, Stone MH, Fisher J. A retrieval study of capital hip prostheses with titanium alloy femoral stems. J Bone Joint Surg 2001;83B: 1195-1201.
8. Iwaki H, Kobayashi Y, Kadoya Y, Revell PA, Al-Saffar N, Yamac T, Scott G, Freeman MAR, Yamano Y, Rehman I. The size shape and number of PMMA bone cement particles in failed total joint replacement. Proceedings of the 45th Annual Meeting of the Orthopaedic Research Society; 1999; p 248.
9. Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J. Production of TNF-α and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000;21:1005-1013.
10. Mitchell W, Matthews JB, Stone MH, Fisher J, Ingham E. Comparison of the response of human peripheral blood mononuclear cells to challenge with particles of three bone cements in vitro. Biomaterials 2003;24:737-748.
11. Sabokbar A, Fujikawa Y, Murray DW, Athanasou NA. Radioopaque agents in bone cement increase bone resorption. J Bone Joint Surg 1997;79B:129-134.
12. Wilcox RK. The biomechanics of vertebroplasty: a review. Proc IMechE J Eng Med 2004;218H:1-10.
13. Besong AA, Tipper JL, Ingham E, Stone MH, Wroblewski BM, Fisher J. Quantitative comparison of wear debris from UHM-WPE that has and has not been sterilised by gamma irradiation. J Bone Joint Surg 1998;80B:340-344.
14. Ingram J, Matthews JB, Tipper JL, Stone MH, Fisher J, Ingham E. Comparison of the biological activity of grade GUR 1120 and GUR 415HP UHMWPE wear debris. Biomed Mater Eng 2002;12:177-188.
15. Miyaguchi M, Kobayashi A, Iwaki H, Ohashi H, Kodoya Y, Yamano Y. Human monocyte response to retrieved polymethylmethacrylate particles. J Biomed Mater Res 2002;62:331-337.
16. Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap PF, Solomon L. Widespread dissemination of metal debris from implants. J Bone Joint Surg 1994;76B:701-712.
17. Tipper JL, Ingham E, Hailey JL, Besong AA, Fisher J, Wroblewski BM, Stone MH. Quantitative analysis of polyethylene wear debris, wear rate and head damage in retrieved Charnley hip prostheses. J Mater Sci Mater Med 2000;11:117-124.
18. Howling GI, Barnett PI, Tipper JL, Stone MH, Fisher J, Ingham E. Quantitative characterization of polyethylene debris isolated from periprosthetic tissue in early failure knee implants and early and late failure Charnley hip implants. J Biomed Mater Res B Appl Biomater 2001;58:415-420.
19. Endo M, Tipper JL, Barton DC, Stone MH, Ingham E, Fisher J. Comparison of wear, wear debris and functional biological activity of moderately crosslinked and non-crosslinked polyethylenes in hip prostheses. Proc IMechE J Eng Med 2002;216H: 111-122.
20. Ingram JH, Stone MH, Fisher J, Ingham E. The influence of molecular weight, crosslinking and counterface roughness on TNF-alpha production by macrophages in response to ultra high molecular weight polyethylene particles. Biomaterials 2004;17: 3511-3522.
21. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. Comparison of the response of primary murine peritoneal macrophages and the U937 human histiocytic cell line to challenge with in vitro generated clinically relevant UHMWPE particles. Biomed Mater Eng 2000a;10:229-240.
22. Matthews JB, Stone MH, Wroblewski BM, Fisher J, Ingham E. Evaluation of the response of primary human peripheral blood mononuclear phagocytes challenged with in vitro generated clinically relevant UHMWPE particles of known size and dose. J Biomed Mater Res B Appl Biomater 2000b;44:296-307.
23. Horowitz SM, Frondoza CG, Lennox DW. Effects of polymethylmethacrylate exposure upon macrophages. J Orthop Res 1988;6:827-832.
24. Horowitz SM, Doty SB, Lane JM, Burstein AH. Studies of the mechanisms by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg Am 1993;75:802-813.
25. Giant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO. Bone resorption activity of particulate stimulated macrophages. J Bone Miner Res 1993;8:1071-1079.
26. Giant TT, Jacobs JJ. Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Bone Joint Surg 1994;12:720-731.
27. Horowitz SM, Purdon MA. Mediator interactions in macrophage/particulate bone resorption. J Biomed Mater Res 1995; 29:477-484.
28. Gonzalez O, Smith RL, Goodman SB. Effect of size, concentration, surface area and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res 1996;30:463-473.
29. Algan SM, Purdon M, Horowitz SM. Role of tumour necrosis factor alpha in particle induced bone resorption. J Orthop Res 1996;14:30-35.
30. Lazarus MD, Cuckler JM, Schumacher HR, Ducheyne P, Baker DG. Comparison of the inflammatory response to particulate polymethylmethacrylate debris with and without barium sulphate. J Orthop Res 1994;12:532-541.
31. Kim KJ, Kobayashi Y, Itoh T. Osteolysis model with continuous infusion of polyethylene particles. Clin Orthop 1998;352: 46-52.
32. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL. Tumour necrosis factor-α mediates'orthopaedic implant osteolysis. Am J Pathol 1991;154:203-210.
33. Schwanz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ. Tumour necrosis factor-alpha/ nuclear transcription factor-kappa B signalling in periprosthetic osteolysis. J Orthop Res 2000;18:472-480.
34. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris induced osteolysis. J Bone Miner Res 2001a;16:338-347.
35. Clohisy JC, Teitelbaum S, Ross FP, Erdmann JM, Abu-Amer Y. Blockade of TNF-activation of NF-kB in osteoclast precursors prevents implant osteolysis. J Bone Miner Res 1999;14:S489.
36. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of anti-tumour necrosis factor gene therapy on wear debris induced osteolysis. J Bone Joint Surg 2001b;83A:1789-1797.
37. Theill LE, Boyle WJ, Penninger JM. RANK-L AND RANK: T cells, bone loss and mammalian evolution. Ann Rev Immunol 2002;20:795-823.
38. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin 1 beta and tumour necrosis factor alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25:255-259.
39. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. Eostrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor mediated stimulation of macrophage colony stimulating factor production. J Biol Chem 1996;271:28890-28897.
40. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Giant TT. Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 1995;13:792-801.